Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Patient Reported Outcome Measures × Endocrine × 1 year × Clear all

Sponsor

Cancer Type

Breast 5 Other neoplasm 2 Other hematologic neoplasm 2 Myeloid 2 Lymphoid 2 Gastrointestinal 2 Sarcoma 1

Interventions

lutetium Lu 177 dotatate 31 Magnetic Resonance Spectroscopy 24 pembrolizumab 20 Specimen Handling 17 Nivolumab 17 cabozantinib 14 Everolimus 14 lenvatinib 12 trametinib 11 gallium Ga 68 dotatate 11 dabrafenib 10 Ipilimumab 10 Carboplatin 9 Cisplatin 8 atezolizumab 7 Temozolomide 7 Lutetium-177 7 Capecitabine 7 surufatinib 6 X-Rays 6 Octreotide 6 olaparib 5 lanreotide 5 cemiplimab 5 Vemurafenib 5 Surveys and Questionnaires 5 Paclitaxel 5 Lutetium 5 Injections 5 Fluorodeoxyglucose F18 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡